Search results
Jun 26, 2024 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers.
May 26, 2022 · NovogeneAIT Genomics Singapore Pte Ltd, one of the largest Next-Generation Sequencing service providers in Asia has been appointed by Illumina to carry out genome sequencing for 100,000 individuals in Singapore as part of the SG100K project.
Illumina | 470,415 followers on LinkedIn. Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic ...
Illumina Singapore Pte. Ltd. provides physical and biological research and development services. The Company offers research in cancer, microbiology, agrigemomics, complex diseases,...
Apr 18, 2023 · SINGAPORE, April 18, 2023 /PRNewswire/ -- Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked 7th overall from 250 companies and 1st in Healthcare...
Illumina came to Singapore more than 10 years ago in 2008. Since then, it has grown from strength to strength, not just increasing its production capacity in Singapore, but very importantly, also helping us to grow the ecosystem of the supporting SMEs working with Illumina to grow their business.
